Hi @Martin37,
that’s undoubtedly the situation now IMO, especially as regards the Lonza Tuas international facility inspection. Given MSB’s confirmation that new assay(s) are involved, an inspection - but logistically might be broken into ‘general’ and ‘release assay specific’ - would probably need to be post-settlement with OTAT of the content of the additional assay(s).
CEO Itescu advised the market some time ago that this inspection sits on the critical path to approval.
As I recall (without checking) he expressed the dependency as ‘determining’ the timing.
Hi @Martin37,that’s undoubtedly the situation now IMO,...
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.5¢ |
Change
0.020(2.26%) |
Mkt cap ! $1.033B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $5.610M | 6.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 317774 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 23500 | 2 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |